135 related articles for article (PubMed ID: 10931372)
1. Vascular endothelial growth factor expression in oligodendrogliomas: a correlative study with Sainte-Anne malignancy grade, growth fraction and patient survival.
Varlet P; Guillamo JS; Nataf F; Koziak M; Beuvon F; Daumas-Duport C
Neuropathol Appl Neurobiol; 2000 Aug; 26(4):379-89. PubMed ID: 10931372
[TBL] [Abstract][Full Text] [Related]
2. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of vascular endothelial growth factor (VEGF C-1) immunoexpression in oligodendroglioma. An analysis of 91 cases.
Korshunov A; Golanov A
J Neurooncol; 2000 May; 48(1):13-9. PubMed ID: 11026692
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of clinical and angiogenesis-related factors in low-grade oligodendrogliomas.
Vaquero J; Zurita M; Coca S; Oya S; Morales C
Surg Neurol; 2000 Sep; 54(3):229-34; discussion 234. PubMed ID: 11118569
[TBL] [Abstract][Full Text] [Related]
5. [Reappraisal of the Sainte-Anne Hospital classification of oligodendrogliomas in view of retrospective studies].
Daumas-Duport C; Koziak M; Miquel C; Nataf F; Jouvet A; Varlet P
Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):247-53. PubMed ID: 16292168
[TBL] [Abstract][Full Text] [Related]
6. Assessment of tumor angiogenesis as a prognostic factor of survival in patients with oligodendroglioma.
Quon H; Hasbini A; Cougnard J; Djafari L; Lacroix C; Abdulkarim B
J Neurooncol; 2010 Jan; 96(2):277-85. PubMed ID: 19618120
[TBL] [Abstract][Full Text] [Related]
7. Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma.
Deininger MH; Weller M; Streffer J; Meyermann R
Cancer; 1999 Nov; 86(9):1832-9. PubMed ID: 10547558
[TBL] [Abstract][Full Text] [Related]
8. Expression and distribution of vascular endothelial growth factor protein in human brain tumors.
Pietsch T; Valter MM; Wolf HK; von Deimling A; Huang HJ; Cavenee WK; Wiestler OD
Acta Neuropathol; 1997 Feb; 93(2):109-17. PubMed ID: 9039457
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclin A and topoisomerase IIalpha of oligodendrogliomas is correlated with tumour grade, MIB-1 labelling index and survival.
Park SH; Suh YL
Histopathology; 2003 Apr; 42(4):395-402. PubMed ID: 12653952
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor and p53 protein in association with neovascularization in human malignant gliomas.
Miyagami M; Tazoe M; Nakamura S
Brain Tumor Pathol; 1998; 15(2):95-100. PubMed ID: 10328546
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas.
Christov C; Adle-Biassette H; Le Guerinel C; Natchev S; Gherardi RK
Neuropathol Appl Neurobiol; 1998 Feb; 24(1):29-35. PubMed ID: 9549726
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas.
Chaudhry IH; O'Donovan DG; Brenchley PE; Reid H; Roberts IS
Histopathology; 2001 Oct; 39(4):409-15. PubMed ID: 11683943
[TBL] [Abstract][Full Text] [Related]
14. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical markers for prognosis of oligodendroglial neoplasms.
Korshunov A; Golanov A; Sycheva R
J Neurooncol; 2002 Jul; 58(3):237-53. PubMed ID: 12187958
[TBL] [Abstract][Full Text] [Related]
16. Recurrence of meningiomas.
Yamasaki F; Yoshioka H; Hama S; Sugiyama K; Arita K; Kurisu K
Cancer; 2000 Sep; 89(5):1102-10. PubMed ID: 10964341
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-1 in astrocytic tumours.
Yao Y; Kubota T; Sato K; Kitai R; Takeuchi H; Arishima H
Acta Neurochir (Wien); 2001; 143(2):159-66. PubMed ID: 11459088
[TBL] [Abstract][Full Text] [Related]
18. Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria.
Daumas-Duport C; Tucker ML; Kolles H; Cervera P; Beuvon F; Varlet P; Udo N; Koziak M; Chodkiewicz JP
J Neurooncol; 1997 Aug; 34(1):61-78. PubMed ID: 9210053
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas.
Kros JM; Hop WC; Godschalk JJ; Krishnadath KK
Cancer; 1996 Sep; 78(5):1107-13. PubMed ID: 8780550
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization grade 2 oligodendroglioma.
Reis-Filho JS; Faoro LN; Carrilho C; Bleggi-Torres LF; Schmitt FC
Cancer; 2000 Feb; 88(4):862-9. PubMed ID: 10679656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
